BioTuesdays

Tag - STXS

Stereotaxis-Logo
Developments

Stereotaxis to acquire Robocath

Stereotaxis (NYSE: STXS) has announced that it has entered into a definitive agreement to acquire closely held Robocath, a venture-backed innovator of robotic techniques for interventional cardiology and...

April 15, 2026
Stereotaxis-Logo
Developments

FDA clears Stereotaxis’ Synchrony system

Stereotaxis (NYSE: STXS) has received FDA 510(k) clearance for its Synchrony system, designed to digitize and modernize the interventional cath lab. According to Stereotaxis, Synchrony is made available with SynX, a...

April 6, 2026
Stereotaxis
Markets

Cowen starts Stereotaxis at OP; PT $6

Cowen launched coverage of Stereotaxis (NYSE American:STXS) with an “outperform” rating and $6 price target. The stock closed at $2.71 on April 8. Genesis is Stereotaxis’ next-generation robotic magnetic navigation...

April 9, 2020
Stereotaxis
Executive Moves

Stereotaxis names Kimberly Peery as CFO

Kimberly Peery Stereotaxis (NYSE American:STXS) appointed Kimberly Peery as CFO, effective October 1, replacing Martin Stammer, who has accepted a position as CFO of a large professional services firm in the St. Louis...

September 18, 2019
Stereotaxis
Markets

Stereotaxis to uplist to NYSE American

The common shares of Stereotaxis (OTCQX:STXS) were approved for listing on the NYSE American exchange, effective with the opening on Sept. 6, with the same stock symbol. They will trade on the OTCQX until the close on...

September 5, 2019